Anteris Technologies (ASX:AVR) said the representatives of the underwriters of its US initial public offering partially exercised the over-allotment option for 78,481 common shares at $6 apiece, less underwriting discounts and commissions of $0.42 per share, according to a Wednesday filing with the Australian bourse.
The representatives are TD Cowen, Barclays, and Cantor. The portion of the over-allotment option that was not exercised lapsed on Jan. 11. Settlement occurred on Jan. 14.
Separately, TD Cowen ceased its market stabilization activities on Jan. 12. During the stabilization period, TD Cowen purchased over 2.1 million common shares for prices ranging from $5.14 to $6 on the Nasdaq market.
Anteris Technologies' shares were up more than 3% in recent Wednesday trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。